Effects of Intermittent Transdermal Nitroglycerin on Occurrence of Ischemia After Patch Removal: Results of the Second Transdermal Intermittent Dosing Evaluation Study (TIDES-II) fn1fn1This study was supported by a grant from Ciba-Geigy Pharmaceuticals, Summit, New Jersey.

Publication | Closed Access

DOI

Citations

References

1997

Year

Carl J. Pepine, Larry M. Lopez, Dawn Bell, Eileen Handberg, Ronald G. Marks, Susan P. McGorray

Journal of the American College of Cardiology

ThrombosisCardiovascular DiseaseIntermittent Transdermal NitroglycerinPharmacotherapyReperfusion InjuryMedicineNew JerseyAtherosclerosisIschemic SyndromeAnesthesiologyPatch Removal